AML - Treatment of Patients who Relapse after Allogeneic Stem Cell Transplantation: Current Best Practices and Experimental Approaches
On Wednesday, March 23 at 1 PM CST, ASTCT presented the second webinar in its AML webinar series sponsored by Vor Biopharma.
Speakers and Moderator:
Moderator: Antonio Vaz de Macedo, MD; Hospital da Policia Militar
Presenter: Reshma Ramlal, MD, FACP; University of Kentucky Markey Cancer Center
Marcos de Lima, MD; Ohio State University
Mark Levis, MD, PhD; Johns Hopkins